Biotech

All Articles

Vertex, hammered through AATD once more, drops 2 resources on throw away stack

.Tip's try to deal with an unusual hereditary condition has reached another drawback. The biotech sh...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of workers

.Vir Medical's second-quarter earnings record wasn't except big information. The provider welcomed a...

Galapagos stops CAR-T cell treatment litigation over Parkinsonism scenario

.Galapagos has stopped briefly enrollment in a trial of a BCMA-directed CAR-T cell therapy, pumping ...

James Wilson leaving Penn to launch 2 brand-new biotechs

.After much more than thirty years, gene treatment trailblazer James Wilson M.D., Ph.D., is leaving ...

3 biotechs make an effort to beat the summer months heat by losing personnel

.As biotechs try to transform a new page in August, a minimum of three business have dropped workers...

venBio lifts $528M for 5th life sciences VC fund

.Pro equity capital agency venBio has raised one more half a billion bucks to purchase biotechs serv...

Otsuka pays for $800M for Jnana and its own clinical-stage PKU medication

.Otsuka Drug has picked up Boston-based Jnana Therapeutics for $800 thousand so the Eastern biotech ...

FibroGen gives up 75% of US personnel as resource fails 2 even more trials

.FibroGen is actually substantially restructuring its company, laying off 75% of its own U.S. worker...

Tracon relax weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has chosen to wind down functions weeks after an injectable immune checkpoin...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...